These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 28712738)

  • 41. A qualitative assessment of West Virginia pharmacist activities and attitude in diabetes management.
    Shatnawi A; Latif DA
    J Eval Clin Pract; 2017 Jun; 23(3):586-592. PubMed ID: 27882650
    [TBL] [Abstract][Full Text] [Related]  

  • 42. DOTx. MED: Pharmacist-delivered interventions to improve care for patients with diabetes.
    American Pharmacists Association
    J Am Pharm Assoc (2003); 2012; 52(1):25-33. PubMed ID: 22173068
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Influence of pharmacy practice on community pharmacists' integration of medication and lab value information from electronic health records.
    Hughes CA; Guirguis LM; Wong T; Ng K; Ing L; Fisher K
    J Am Pharm Assoc (2003); 2011; 51(5):591-8. PubMed ID: 21896456
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacist engagement in a community pharmacy hypertension management program in collaboration with an academic medical center.
    Vordenberg SE; Kim J; Serlin DC; Fan AL; Choe HM
    Am J Health Syst Pharm; 2022 Jun; 79(13):1110-1114. PubMed ID: 35278307
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of the economic and clinical impact of community pharmacist-driven pharmacy benefit management services.
    Jackson DL; Michaels NM; Melson B; Bruder E; Rhodes LA; Marciniak MW
    J Am Pharm Assoc (2003); 2019; 59(4S):S91-S94. PubMed ID: 31203015
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A randomized controlled study of practice facilitation to improve the provision of medication management services in Alberta community pharmacies.
    Houle SK; Charrois TL; Faruquee CF; Tsuyuki RT; Rosenthal MM
    Res Social Adm Pharm; 2017; 13(2):339-348. PubMed ID: 27017157
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of Pharmacists' Work in a Physician-Pharmacist Collaborative Model for the Management of Hypertension.
    Isetts BJ; Buffington DE; Carter BL; Smith M; Polgreen LA; James PA
    Pharmacotherapy; 2016 Apr; 36(4):374-84. PubMed ID: 26893135
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacogenomics in a community pharmacy: ACT now.
    Padgett L; O'Connor S; Roederer M; McLeod H; Ferreri S
    J Am Pharm Assoc (2003); 2011; 51(2):189-93. PubMed ID: 21382809
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cost-effectiveness of Wisconsin TEAM model for improving adherence and hypertension control in black patients.
    Shireman TI; Svarstad BL
    J Am Pharm Assoc (2003); 2016; 56(4):389-96. PubMed ID: 27184784
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Can a pharmacy intervention improve the metabolic risks of mental health patients? Evaluation of a novel collaborative service.
    Maulavizada H; Emmerton L; Hattingh HL
    BMC Health Serv Res; 2016 Apr; 16():146. PubMed ID: 27112344
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Testing the organizational theory of innovation implementation effectiveness in a community pharmacy medication management program: a hurdle regression analysis.
    Turner K; Trogdon JG; Weinberger M; Stover AM; Ferreri S; Farley JF; Ray N; Patti M; Renfro C; Shea CM
    Implement Sci; 2018 Jul; 13(1):105. PubMed ID: 30064454
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evaluation of the implementation process and outcomes of a professional pharmacy service in a community pharmacy setting. A case report.
    Garcia-Cardenas V; Benrimoj SI; Ocampo CC; Goyenechea E; Martinez-Martinez F; Gastelurrutia MA
    Res Social Adm Pharm; 2017; 13(3):614-627. PubMed ID: 27423785
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The paradox of pharmacy: A profession's house divided.
    Brown D
    J Am Pharm Assoc (2003); 2012; 52(6):e139-43. PubMed ID: 23143300
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development and implementation of a collaboration between a patient-centered medical home and community pharmacy.
    Stafford RA; Garrett LN; Bates KA; Diemer TB; Thomas JL; Smith MG; Teeter BS; Curran GM
    J Am Pharm Assoc (2003); 2020; 60(1):122-129. PubMed ID: 31870861
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Establishment, Implementation, and Consolidation of Clinical Pharmacy Services in Community Pharmacies: Perceptions of a Group of Pharmacists.
    Dosea AS; Brito GC; Santos LMC; Marques TC; Balisa-Rocha B; Pimentel D; Bueno D; Lyra DP
    Qual Health Res; 2017 Feb; 27(3):363-373. PubMed ID: 26658232
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of community pharmacy-based services for type-2 diabetes in an Indonesian setting: pharmacist survey.
    Wibowo Y; Parsons R; Sunderland B; Hughes J
    Int J Clin Pharm; 2015 Oct; 37(5):873-82. PubMed ID: 25986291
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Project to Promote Adherence to Blood Pressure Medication Among People Who Use Community Pharmacies in Rural Montana, 2014-2016.
    Oser CS; Fogle CC; Bennett JA
    Prev Chronic Dis; 2017 Jun; 14():E52. PubMed ID: 28662759
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The (cost-)effectiveness of a patient-tailored intervention programme to enhance adherence to antihypertensive medication in community pharmacies: study protocol of a randomised controlled trial.
    van der Laan DM; Elders PJ; Boons CC; Bosmans JE; Nijpels G; Hugtenburg JG
    Trials; 2017 Jan; 18(1):29. PubMed ID: 28103948
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Attitudes toward and factors affecting implementation of medication therapy management services by community pharmacists.
    MacIntosh C; Weiser C; Wassimi A; Reddick J; Scovis N; Guy M; Boesen K
    J Am Pharm Assoc (2003); 2009; 49(1):26-30. PubMed ID: 19196593
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Implementation and barriers to uptake of interactive voice response technology aimed to improve blood pressure control at a large academic medical center.
    Ashjian EJ; Yoo A; Piette JD; Choe HM; Thompson AN
    J Am Pharm Assoc (2003); 2019; 59(2S):S104-S109.e1. PubMed ID: 30660451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.